PXS
Click for more information
0.00% 8.5¢ pharmaxis ltd

Company Update on CDI Clinical Trial and New Strategic Focus, page-2

  1. newB
    3,534 Posts.
    lightbulb Created with Sketch. 64
    clock Created with Sketch.
    19/03/19
    10:45
    Post #: 37806821
    Sorry should say this is for IMC, their Nash Phase 3 seems not going to happen, BI has one less competitor...
    PXS Price at posting: 26.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add PXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.